Glaukos Corp Stock Net Income
| GKOS Stock | USD 124.27 4.29 3.58% |
As of the 27th of January, Glaukos Corp retains the market risk adjusted performance of 0.8091, and Risk Adjusted Performance of 0.2018. Glaukos Corp technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Glaukos Corp coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Glaukos Corp is priced fairly, providing market reflects its last-minute price of 124.27 per share. Given that Glaukos Corp has jensen alpha of 0.7133, we strongly advise you to confirm Glaukos Corp's regular market performance to make sure the company can sustain itself at a future point.
Glaukos Corp Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 14.3068 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -131.7 M | -125.1 M | |
| Net Loss | -131.7 M | -125.1 M | |
| Net Loss | -89.3 M | -84.8 M | |
| Net Loss | (2.50) | (2.62) | |
| Net Income Per E B T | 0.90 | 0.69 |
Glaukos | Net Income | Build AI portfolio with Glaukos Stock |
Latest Glaukos Corp's Net Income Growth Pattern
Below is the plot of the Net Income of Glaukos Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Glaukos Corp financial statement analysis. It represents the amount of money remaining after all of Glaukos Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Glaukos Corp's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Glaukos Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (146.37 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Glaukos Net Income Regression Statistics
| Arithmetic Mean | (54,126,345) | |
| Coefficient Of Variation | (106.13) | |
| Mean Deviation | 50,905,976 | |
| Median | (19,331,000) | |
| Standard Deviation | 57,442,243 | |
| Sample Variance | 3299.6T | |
| Range | 161.8M | |
| R-Value | (0.78) | |
| Mean Square Error | 1372.1T | |
| R-Squared | 0.61 | |
| Significance | 0.0002 | |
| Slope | (8,885,478) | |
| Total Sum of Squares | 52793.8T |
Glaukos Net Income History
Other Fundumenentals of Glaukos Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Glaukos Corp Net Income component correlations
Glaukos Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Glaukos Corp is extremely important. It helps to project a fair market value of Glaukos Stock properly, considering its historical fundamentals such as Net Income. Since Glaukos Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Glaukos Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Glaukos Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Glaukos Corp. If investors know Glaukos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Glaukos Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 18.963 | Earnings Share (1.54) | Revenue Per Share | Quarterly Revenue Growth 0.381 | Return On Assets |
The market value of Glaukos Corp is measured differently than its book value, which is the value of Glaukos that is recorded on the company's balance sheet. Investors also form their own opinion of Glaukos Corp's value that differs from its market value or its book value, called intrinsic value, which is Glaukos Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Glaukos Corp's market value can be influenced by many factors that don't directly affect Glaukos Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Glaukos Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Glaukos Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Glaukos Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Glaukos Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Glaukos Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Glaukos Corp.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Glaukos Corp on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Glaukos Corp or generate 0.0% return on investment in Glaukos Corp over 90 days. Glaukos Corp is related to or competes with TransMedics, IRhythm Technologies, Bausch Lomb, Merit Medical, Bruker, Alkermes Plc, and Arcellx. Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel th... More
Glaukos Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Glaukos Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Glaukos Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.81 | |||
| Information Ratio | 0.2376 | |||
| Maximum Drawdown | 19.15 | |||
| Value At Risk | (1.94) | |||
| Potential Upside | 5.35 |
Glaukos Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Glaukos Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Glaukos Corp's standard deviation. In reality, there are many statistical measures that can use Glaukos Corp historical prices to predict the future Glaukos Corp's volatility.| Risk Adjusted Performance | 0.2018 | |||
| Jensen Alpha | 0.7133 | |||
| Total Risk Alpha | 0.4931 | |||
| Sortino Ratio | 0.393 | |||
| Treynor Ratio | 0.7991 |
Glaukos Corp January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2018 | |||
| Market Risk Adjusted Performance | 0.8091 | |||
| Mean Deviation | 2.08 | |||
| Semi Deviation | 1.35 | |||
| Downside Deviation | 1.81 | |||
| Coefficient Of Variation | 377.88 | |||
| Standard Deviation | 3.0 | |||
| Variance | 8.97 | |||
| Information Ratio | 0.2376 | |||
| Jensen Alpha | 0.7133 | |||
| Total Risk Alpha | 0.4931 | |||
| Sortino Ratio | 0.393 | |||
| Treynor Ratio | 0.7991 | |||
| Maximum Drawdown | 19.15 | |||
| Value At Risk | (1.94) | |||
| Potential Upside | 5.35 | |||
| Downside Variance | 3.28 | |||
| Semi Variance | 1.83 | |||
| Expected Short fall | (2.76) | |||
| Skewness | 1.69 | |||
| Kurtosis | 5.47 |
Glaukos Corp Backtested Returns
Glaukos Corp appears to be very steady, given 3 months investment horizon. Glaukos Corp holds Efficiency (Sharpe) Ratio of 0.27, which attests that the entity had a 0.27 % return per unit of standard deviation over the last 3 months. By evaluating Glaukos Corp's technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please utilize Glaukos Corp's risk adjusted performance of 0.2018, and Market Risk Adjusted Performance of 0.8091 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Glaukos Corp holds a performance score of 21. The company retains a Market Volatility (i.e., Beta) of 0.98, which attests to possible diversification benefits within a given portfolio. Glaukos Corp returns are very sensitive to returns on the market. As the market goes up or down, Glaukos Corp is expected to follow. Please check Glaukos Corp's coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Glaukos Corp's current trending patterns will revert.
Auto-correlation | 0.40 |
Average predictability
Glaukos Corp has average predictability. Overlapping area represents the amount of predictability between Glaukos Corp time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Glaukos Corp price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Glaukos Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 22.76 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Glaukos Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Glaukos Corp reported net income of (146.37 Million). This is 142.89% lower than that of the Health Care Equipment & Supplies sector and 161.47% lower than that of the Health Care industry. The net income for all United States stocks is 125.64% higher than that of the company.
Glaukos Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Glaukos Corp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Glaukos Corp could also be used in its relative valuation, which is a method of valuing Glaukos Corp by comparing valuation metrics of similar companies.Glaukos Corp is currently under evaluation in net income category among its peers.
Glaukos Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Glaukos Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Glaukos Corp's managers, analysts, and investors.Environmental | Governance | Social |
Glaukos Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Glaukos Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Glaukos Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Glaukos Corp's value.| Shares | William Blair Investment Management, Llc | 2025-06-30 | 1.1 M | Hhg Plc | 2025-06-30 | 1.1 M | Holocene Advisors, Lp | 2025-06-30 | 1 M | Amvescap Plc. | 2025-06-30 | 997.1 K | Capital World Investors | 2025-06-30 | 850.9 K | Norges Bank | 2025-06-30 | 738.8 K | Point72 Asset Management, L.p. | 2025-06-30 | 719.3 K | Gilder Gagnon Howe & Co Llc | 2025-06-30 | 700.6 K | Charles Schwab Investment Management Inc | 2025-06-30 | 700.5 K | Blackrock Inc | 2025-06-30 | 8.7 M | Fmr Inc | 2025-06-30 | 6.3 M |
Glaukos Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0574 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 6.72 B | ||||
| Shares Outstanding | 57.43 M | ||||
| Shares Owned By Insiders | 3.29 % | ||||
| Shares Owned By Institutions | 96.71 % | ||||
| Number Of Shares Shorted | 2.02 M | ||||
| Price To Earning | 94.70 X | ||||
| Price To Book | 8.95 X | ||||
| Price To Sales | 14.67 X | ||||
| Revenue | 383.48 M | ||||
| Gross Profit | 361.14 M | ||||
| EBITDA | (95.64 M) | ||||
| Net Income | (146.37 M) | ||||
| Cash And Equivalents | 391.19 M | ||||
| Cash Per Share | 8.22 X | ||||
| Total Debt | 105.87 M | ||||
| Debt To Equity | 0.68 % | ||||
| Current Ratio | 6.78 X | ||||
| Book Value Per Share | 13.41 X | ||||
| Cash Flow From Operations | (61.32 M) | ||||
| Short Ratio | 3.03 X | ||||
| Earnings Per Share | (1.54) X | ||||
| Price To Earnings To Growth | 1.64 X | ||||
| Target Price | 130.77 | ||||
| Number Of Employees | 995 | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 6.89 B | ||||
| Total Asset | 974.76 M | ||||
| Retained Earnings | (745.44 M) | ||||
| Working Capital | 374.67 M | ||||
| Current Asset | 104.14 M | ||||
| Current Liabilities | 20.36 M | ||||
| Net Asset | 974.76 M |
About Glaukos Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Glaukos Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glaukos Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glaukos Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.